So my friend, Justin Morgenstern recently put up a post on Idarucizumab, aka Praxbind. He seemed pretty fired up on the issue, so I got him on the line to talk about it. What follows is a conversation on evidence and what to do when there is not a good amount of it.
Justin Wrote an Additional Post after our Discussion
On to the Wee…
Latest posts by Scott Weingart (see all)
- EMCrit Wee – Semper Vitae – GRM with Helen Perry - July 20, 2019
- EMCrit 251 – Philosophical & Psychological Diversions Part II – Naive Reality and the Fundamental Attribution Error - July 16, 2019
- EMCrit 249 – You Can Either Learn or You Can Blame – Fixing the Morbidity and Mortality Conference with George Douros - June 13, 2019